Prenatal diagnosis after ART success: The role of early combined screening tests in counselling pregnant patients

Placenta

Volumn 24, Issue SUPPL. B, 2003, Pages

  Ghisoni, L ^a   Ferrazzi, Enrico ^a   Castagna, C ^a   Levi Setti, P E ^b   Masini, A C ^a   Pigni, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ALGORITHM; ARTICLE; CALCULATION; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FERTILIZATION IN VITRO; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MATERNAL AGE; PATIENT COUNSELING; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; TRISOMY;

EID: 0142181094     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4004(03)00178-4     Document Type: Article

References (11)

1. Heinonen S, Ryynanen M, Kirkinen P, Hippelainen M & Saarikoski S (1996) Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening. Fertil Steril, 66, 398-403.
2. Koulischer S, Verloes A, Lesenfants S, et al. (1997) Genetic risk in natural and medically assisted procreation. Early Pregnancy, 3, 164-171.
3. Krantz DA, Hallahan TW, Orlandi F, et al. (2000) First trimester Down syndrome screening using dried blood biochemistry and nuchal translucency. Obstet Gynecol, 96, 207-213.
4. Liao AW, Heath V, Kametas N, Spencer K & Nicolaides KH (2001) First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Human Reproduction, 16, 1501-1504.
5. Maymon R & Shulman A (2002) Serial first-and second-trimester Down's syndrome screening tests among IVF- versus naturally-conceived singletons. Human Reproduction, 17, 1081-1085.
6. Orlandi F, Rossi C, Allegra A, Krantz D, Hallahan T, Orlandi E & Macri J (2002) First trimester screening with free beta-HCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenatal Diagnosis, 22, 718-721.
7. Raty R, Virtanen A, Koskinen P, Laitinen P, Forsstrom J, Salonen R, Morsky P & Ekblad U (2000) Maternal midtrimester serum AFP and free beta-hCG levels in vitro fertilization twin pregnancies. Prenatal Diagnosis, 20, 221-223.
8. Ribbert LSM, Kornmann LH, de Wolf BTHM, Simons AHM, Jansen CAM, Beekhuis JR & Mantingh A (1996) Maternal serum screening for fetal Down syndrome in IVF pregnancies. Prenatal Diagnosis, 16, 35-38.
9. Spencer K, Souter V, Tul N, et al. (1999) A rapid screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-hCG and PAPP-A. Ultrasound Obstet Gynecol, 13, 231-237.
10. Van Steirteghem A (2001) Twenty years of in vitro fertilization: realization and questions for the future.Verh K Acad Geneeskd Belg, 63, 193-240. discussion 240-241..
11. Wojdemann KR, Larsen SO, Shalmi A, Sundberg K, Christiansen M & Tabor A (2001) First trimester screening for Down syndrome and assisted reproduction: no basis for concern. Prenatal Diagnosis, 21,